UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics

Advanced drug delivery reviews, 2018-10, Vol.135, p.62-74

2018

Volltextzugriff (PDF)

Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain

PloS one, 2013-04, Vol.8 (4), p.e59749-e59749

2013

Volltextzugriff (PDF)

Fatty Acid-Binding Protein 5 Facilitates the Blood–Brain Barrier Transport of Docosahexaenoic Acid

Molecular pharmaceutics, 2015-12, Vol.12 (12), p.4375-4385

2015

Volltextzugriff (PDF)

Altered Brain Uptake of Therapeutics in a Triple Transgenic Mouse Model of Alzheimer’s Disease

Pharmaceutical research, 2013-11, Vol.30 (11), p.2868-2879

2013

Volltextzugriff (PDF)

Development and application of a novel cervical lymph collection method to assess lymphatic transport in rats

Frontiers in pharmacology, 2023-01, Vol.14, p.1111617-1111617

2023

Volltextzugriff (PDF)

Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function

The Journal of neuroscience, 2016-11, Vol.36 (46), p.11755-11767

2016

Volltextzugriff (PDF)

The hyperpolarization‐activated cyclic nucleotide‐gated 4 channel as a potential anti‐seizure drug target

British journal of pharmacology, 2020-08, Vol.177 (16), p.3712-3729

2020

Volltextzugriff (PDF)

Incorporation of MyDispense, a Virtual Pharmacy Simulation, into Extemporaneous Formulation Laboratories

Healthcare (Basel), 2022-08, Vol.10 (8), p.1489

2022

Volltextzugriff (PDF)

Memantine Transport across the Mouse Blood–Brain Barrier Is Mediated by a Cationic Influx H+ Antiporter

Molecular pharmaceutics, 2013-12, Vol.10 (12), p.4491-4498

2013

Volltextzugriff (PDF)

Altered Expression of Small Intestinal Drug Transporters and Hepatic Metabolic Enzymes in a Mouse Model of Familial Alzheimer’s Disease

Molecular pharmaceutics, 2018-09, Vol.15 (9), p.4073-4083

2018

Volltextzugriff (PDF)

Altered blood–brain barrier and blood–spinal cord barrier dynamics in amyotrophic lateral sclerosis: Impact on medication efficacy and safety

British journal of pharmacology, 2022-06, Vol.179 (11), p.2577-2588

2022

Volltextzugriff (PDF)

Intestinal Permeability and Oral Absorption of Selected Drugs Are Reduced in a Mouse Model of Familial Alzheimer’s Disease

Molecular pharmaceutics, 2020-05, Vol.17 (5), p.1527-1537

2020

Volltextzugriff (PDF)

Species-Dependent Blood-Brain Barrier Disruption of Lipopolysaccharide: Amelioration by Colistin In Vitro and In Vivo

Antimicrobial Agents and Chemotherapy, 2013-09, Vol.57 (9), p.4336-4342

2013

Volltextzugriff (PDF)

Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (−)-epigallocatechin gallate

European journal of pharmaceutical sciences, 2010-10, Vol.41 (2), p.219-225

2010

Volltextzugriff (PDF)

Altered Blood-Brain Barrier Dynamics in the C9orf72 Hexanucleotide Repeat Expansion Mouse Model of Amyotrophic Lateral Sclerosis

Pharmaceutics, 2022-12, Vol.14 (12), p.2803

2022

Volltextzugriff (PDF)

Cu(ATSM) Increases P-Glycoprotein Expression and Function at the Blood-Brain Barrier in C57BL6/J Mice

Pharmaceutics, 2023-08, Vol.15 (8), p.2084

2023

Volltextzugriff (PDF)

Impact of P-Glycoprotein Inhibition and Lipopolysaccharide Administration on Blood-Brain Barrier Transport of Colistin in Mice

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.502-507

2011

Volltextzugriff (PDF)

Chitosan nanoparticles enhance the plasma exposure of (−)-epigallocatechin gallate in mice through an enhancement in intestinal stability

European journal of pharmaceutical sciences, 2011-10, Vol.44 (3), p.422-426

2011

Volltextzugriff (PDF)

Effect of Systemic Infection Induced by Pseudomonas aeruginosa on the Brain Uptake of Colistin in Mice

Antimicrobial Agents and Chemotherapy, 2012-10, Vol.56 (10), p.5240-5246

2012

Volltextzugriff (PDF)

Effect of Apolipoprotein E isoforms on the Abundance and Function of P-glycoprotein in Human Brain Microvascular Endothelial Cells

Pharmaceutical research, 2024-07, Vol.41 (7), p.1427-1441

2024

Volltextzugriff (PDF)

Plasma, brain and spinal cord concentrations of caffeine are reduced in the SOD1G93A mouse model of amyotrophic lateral sclerosis following oral administration

European journal of pharmaceutics and biopharmaceutics, 2024-10, Vol.203, p.114434, Article 114434

2024

Volltextzugriff (PDF)

Development of a Vertically Integrated Pharmacy Degree

Pharmacy, 2021-09, Vol.9 (4), p.156

2021

Volltextzugriff (PDF)

Effective use of reducing agents and nanoparticle encapsulation in stabilizing catechins in alkaline solution

Food chemistry, 2010-10, Vol.122 (3), p.662-667

2010

Volltextzugriff (PDF)

Fatty Acid Binding Proteins Expressed at the Human Blood–Brain Barrier Bind Drugs in an Isoform-Specific Manner

Pharmaceutical research, 2015-10, Vol.32 (10), p.3432-3446

2015

Volltextzugriff (PDF)

From the gut to the blood–brain barrier: Novel approaches for the treatment and targeted delivery of therapeutics in Alzheimer’s disease

Advanced drug delivery reviews, 2023-05, Vol.196, p.114818-114818, Article 114818

2023

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(123)

Publikationsform

Artikel
(128)

Sprache

Englisch
(128)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics

Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain

Fatty Acid-Binding Protein 5 Facilitates the Blood–Brain Barrier Transport of Docosahexaenoic Acid

Altered Brain Uptake of Therapeutics in a Triple Transgenic Mouse Model of Alzheimer’s Disease

Development and application of a novel cervical lymph collection method to assess lymphatic transport in rats

Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function

The hyperpolarization‐activated cyclic nucleotide‐gated 4 channel as a potential anti‐seizure drug target

Incorporation of MyDispense, a Virtual Pharmacy Simulation, into Extemporaneous Formulation Laboratories

Memantine Transport across the Mouse Blood–Brain Barrier Is Mediated by a Cationic Influx H+ Antiporter

Altered Expression of Small Intestinal Drug Transporters and Hepatic Metabolic Enzymes in a Mouse Model of Familial Alzheimer’s Disease

Altered blood–brain barrier and blood–spinal cord barrier dynamics in amyotrophic lateral sclerosis: Impact on medication efficacy and safety

Intestinal Permeability and Oral Absorption of Selected Drugs Are Reduced in a Mouse Model of Familial Alzheimer’s Disease

Species-Dependent Blood-Brain Barrier Disruption of Lipopolysaccharide: Amelioration by Colistin In Vitro and In Vivo

Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (−)-epigallocatechin gallate

Altered Blood-Brain Barrier Dynamics in the C9orf72 Hexanucleotide Repeat Expansion Mouse Model of Amyotrophic Lateral Sclerosis

Cu(ATSM) Increases P-Glycoprotein Expression and Function at the Blood-Brain Barrier in C57BL6/J Mice

Impact of P-Glycoprotein Inhibition and Lipopolysaccharide Administration on Blood-Brain Barrier Transport of Colistin in Mice

Chitosan nanoparticles enhance the plasma exposure of (−)-epigallocatechin gallate in mice through an enhancement in intestinal stability

Effect of Systemic Infection Induced by Pseudomonas aeruginosa on the Brain Uptake of Colistin in Mice

Effect of Apolipoprotein E isoforms on the Abundance and Function of P-glycoprotein in Human Brain Microvascular Endothelial Cells

Plasma, brain and spinal cord concentrations of caffeine are reduced in the SOD1G93A mouse model of amyotrophic lateral sclerosis following oral administration

Development of a Vertically Integrated Pharmacy Degree

Effective use of reducing agents and nanoparticle encapsulation in stabilizing catechins in alkaline solution

Fatty Acid Binding Proteins Expressed at the Human Blood–Brain Barrier Bind Drugs in an Isoform-Specific Manner

From the gut to the blood–brain barrier: Novel approaches for the treatment and targeted delivery of therapeutics in Alzheimer’s disease

Suchergebnisse filtern